Thyrocare acquires Polo Labs’ pathology diagnostic biz
IMT News Desk
Polo Labs, based out of Punjab, is a pathology diagnostic company with 14 laboratories across Punjab, Haryana, and Himachal Pradesh
Thyrocare has entered into a business transfer agreement with Polo Labs to acquire the pathology diagnostic business. The strategic acquisition expands Thyrocare’s Footprints into the Northern part of India, further solidifying its position as a dominant player in the Indian diagnostic industry.
Polo Labs, based out of Punjab, is a well-established pathology diagnostic company with 14 laboratories across Punjab, Haryana, and Himachal Pradesh. The robust network and expertise in the region make them a valuable addition to Thyrocare's operations. Currently, Polo Labs serves a substantial client base and has a significant market presence in Northern India, contributing to the region's healthcare infrastructure.
By integrating Polo Labs' existing network with Thyrocare's advanced diagnostic infrastructure, the company aims to deliver improved service delivery, faster turnaround times, and unmatched patient convenience.
Rahul Guha, MD and CEO, Thyrocare Technologies and President, API Holdings, stated, "The strategic acquisition will enhance our diagnostic capabilities and service offerings, leveraging Polo Labs' existing widespread network in North India. We are committed to a seamless integration and look forward to the growth and innovation this acquisition will bring. Together, we will continue to provide exceptional diagnostic services to a broader client base."
